Australia's Imugene hits near 3-year low on discounted share placement

Imugene

18/08/2023 01:45

** Shares of Australia's Imugene  IMU.AX  fall 14.9% to
A$0.080, hits lowest since Nov. 13, 2020
    ** Stock set to mark worst day since Oct.28, 2022 
    ** Clinical-stage immune-oncology company completes A$35
million ($22.45 million) share placement at an issue price of
A$0.084 per share 
    ** Offer price is at a discount of 10.6% to the last close
of co
    ** Stock has fallen 35.2% this year as of last close


($1 = 1.5593 Australian dollars)
    
    

 (Reporting by Nausheen Thusoo in Bengaluru)
 ((Nausheen.Thusoo@thomsonreuters.com;))